Abbott Laboratories (ABT)

44.55
0.12 0.27
NYSE : Health Care
Prev Close 44.67
Open 44.63
Day Low/High 44.36 / 44.66
52 Wk Low/High 36.76 / 45.84
Volume 4.41M
Avg Volume 8.63M
Exchange NYSE
Shares Outstanding 1.73B
Market Cap 77.24B
EPS 0.90
P/E Ratio 62.96
Div & Yield 1.06 (2.40%)

Latest News

Mylan Hit After Abbott Dumps Shares

Mylan Hit After Abbott Dumps Shares

The company decreased its 13% stake in Mylan Friday.

Can Abbott Outperform Despite Alere?

Can Abbott Outperform Despite Alere?

Abbott Laboratories appears poised to enjoy a fruitful year, though its litigation with former takeover target Alere could hold it back.

Abbott Labs Is Set to Go Substantially Higher

Abbott Labs Is Set to Go Substantially Higher

Here are the levels to watch and act on.

Late-Breaking Data Shows The CardioMEMS HF System Is Effective In Reducing Heart Failure Hospitalizations And Cost Of Care

Late-Breaking Data Shows The CardioMEMS HF System Is Effective In Reducing Heart Failure Hospitalizations And Cost Of Care

PRESENTED AT ACC AND PUBLISHED IN JOURNAL OF AMERICAN COLLEGE OF CARDIOLOGY, THE CARDIOMEMS™ HF SYSTEM OFFERS SUSTAINED BENEFITS FOR PATIENTS SUFFERING FROM SYMPTOMATIC HEART FAILURE

Dow, S&P 500 Retreat From Rally as Health Care Selloff Interrupts Fed Boost

Dow, S&P 500 Retreat From Rally as Health Care Selloff Interrupts Fed Boost

Investor sentiment soured on Thursday as a selloff in health care challenges optimism over the Federal Reserve's decision to raise interest rates.

S&P 500 Trades Lower as Health Care Sells Off, Crude Fluctuates

S&P 500 Trades Lower as Health Care Sells Off, Crude Fluctuates

Stocks are slightly lower by early afternoon Thursday as a selloff in health care challenges optimism over the Federal Reserve's decision to raise interest rates.

Stocks Extend Declines as Biogen Leads Health Care Selloff

Stocks Extend Declines as Biogen Leads Health Care Selloff

Early morning gains quickly evaporate on Thursday as a selloff in health care overshadows the Federal Reserve's decision a day earlier to raise interest rates.

Abbott Laboratories Stock Downgraded by BMO

Abbott Laboratories Stock Downgraded by BMO

Abbott Laboratories downgraded to 'market perform.'

AbbVie, Abbott Laboratories, Amplify Snacks, Skyworks Solutions: 'Mad Money' Lightning Round

AbbVie, Abbott Laboratories, Amplify Snacks, Skyworks Solutions: 'Mad Money' Lightning Round

Jim Cramer is bullish on AbbVie and Abbott Laboratories, but he's bearish on Sonic and Ionis Pharmaceuticals.

This Bull Could Feel the Chill: Cramer's 'Mad Money' Monday Recap

This Bull Could Feel the Chill: Cramer's 'Mad Money' Monday Recap

Cramer still thinks we need a rate hike, but he's ready for a backlash in some sectors -- and you should be, too.

Who Are the Best Employers for Working Mothers?

Who Are the Best Employers for Working Mothers?

Female representation among the top 10% of earners at the NAFE top companies increased 2% to 41%, the highest since 2013.

Analysts' Actions -- Kimberly-Clark, IberiaBank, Ionis Pharma, Actuant and More

Analysts' Actions -- Kimberly-Clark, IberiaBank, Ionis Pharma, Actuant and More

Here are Friday's top research calls, including upgrades for IberiaBank and Actuant, and downgrades for Kimberly-Clark and Ionis Pharma.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ABT, HIHO, KE, LBRDA, SSP, TLRD, VIV Downgrades: CORE, LMNX, PKOH, SIM, TATT, TTEC Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

AbbVie Is a Screaming Dividend Growth Buy... Here's Why

AbbVie Is a Screaming Dividend Growth Buy... Here's Why

AbbVie is unloved by the market, but the stock is poised to generate double-digit returns for shareholders. In addition, AbbVie currently has a high yield of 4.0%.

Updates to Indices/Core Holdings and Bullpen; Thanks!

Check out the latest versions of our Investment Indices and Core Holdings as well as 8 Bullpen additions.

Cramer: Top 10 Bull Markets Right Now (Part 1)

Cramer: Top 10 Bull Markets Right Now (Part 1)

Bull market number one, perhaps of all time: the financials.

Cramer: Top 10 Bull Markets Right Now

Cramer: Top 10 Bull Markets Right Now

Bull market number one, perhaps of all time: the financials.

Cramer: Money's Being Thrown at Almost Everything in the Market

Cramer: Money's Being Thrown at Almost Everything in the Market

There are nearly too many surging sectors to count.

Cramer: Money's Being Thrown at Almost Everything in the Market

Cramer: Money's Being Thrown at Almost Everything in the Market

There are nearly too many surging sectors to count.

Exiting Two Retail Positions

We'll sell our remaining shares in Panera and Costco to protect profits and move on.

FTC Settles Charges of Anti-Competition in Abbot, St. Jude Deal

FTC Settles Charges of Anti-Competition in Abbot, St. Jude Deal

Abbott Labs completed the acquisition of St. Jude Medical in January.

High-Powered Insiders Are Buying These 5 Stocks; Should You?

High-Powered Insiders Are Buying These 5 Stocks; Should You?

Insiders at these companies -- including Tailored Brands and Qualcomm -- have been scooping up shares of their own stock lately.

These Are the 5 Perfect Dividend Stocks for Today's Market

These Are the 5 Perfect Dividend Stocks for Today's Market

Abbott Labs is one of four names to own.

Bullish and Bearish Reversals for the Week

Bullish and Bearish Reversals for the Week

These stocks are indicating a change in direction.